|
May 15, 2023
|
Kinarus secures CHF1.5m financing
|
|
|
Dec 07, 2022
|
Antiviral activity against Omicron BA.2 and BA.5
|
|
|
Nov 24, 2022
|
USPTO allows method-of-use KIN001 patent
|
|
|
Oct 03, 2022
|
KINETIC study discontinued
|
|
|
Sep 05, 2022
|
H122 results reflect continued progress
|
|
|
Aug 31, 2022
|
Phase II COVID-19 outpatient study underway
|
|
|
Aug 24, 2022
|
A unique combination targeting unmet needs
|
|
